2-Dodecyl-6-Methoxycyclohexa-2, 5-Diene-1, 4-Dione isolated from Averrhoa carambola L. root inhibits high glucose-induced EMT in HK-2 cells through targeting the regulation of miR-21–5p/Smad7 signaling pathway - 29/02/24
Abstract |
Objective |
2-Dodecyl-6-Methoxycyclohexa-2, 5-Diene-1, 4-Dione (DMDD) isolated from Averrhoa carambola L. root, has been proven therapeutic effects on diabetic kidney disease (DKD). This research aims to assess DMDD’s effects on DKD and to investigate its underlying mechanisms, to establish DMDD as a novel pharmaceutical agent for DKD treatment.
Methods |
The human renal tubular epithelial (HK-2) cells were induced by high glucose (HG) to mimic DKD and followed by DMDD treatment. The cytotoxicity of DMDD was assessed using the Cell Counting Kit-8 (CCK-8) assay. The migratory capacity of HK-2 cells was evaluated through transwell and scratch-wound assays. To investigate the effect of Smad7 and miR-21–5p, lentiviral transfection was employed in HK-2 cells. Additionally, the expression of proteins related to epithelial-mesenchymal transition (EMT) and TGFβ1/Smad2/3 pathway was checked by QRT-PCR, Western blot, and immunofluorescence techniques.
Results |
This study has shown that DMDD significantly suppresses cell migration and the expression of Vimentin, α-SMA, TGFβ1, and p-Smad2/3 in HK-2 cells under HG conditions. Concurrently, DMDD enhances the protein expression of E-cadherin and Smad7. Intriguingly, the therapeutic effect of DMDD was abrogated upon Smad7 silencing. Further investigations revealed that DMDD effectively inhibits miR-21–5p expression, which is upregulated by HG. Downregulation of miR-21–5p inhibits the activation of the TGFβ1/Smad2/3 pathway and EMT induced by HG. In contrast, overexpression of miR-21–5p negates DMDD’s therapeutic benefits.
Conclusion |
DMDD mitigates EMT in HG-induced HK-2 cells by modulating the miR-21–5p/Smad7 pathway, thereby inhibiting renal fibrosis in DKD. These findings suggest that DMDD holds promise as a potential therapeutic agent for DKD.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | DMDD can effectively ameliorate epithelial-mesenchymal transition in high glucose-induced HK-2 cells. |
• | DMDD inhibits the activation of the TGFβ1/Smad2/3 signaling pathway in high glucose-induced HK-2 cells. |
• | DMDD can inhibit epithelial-mesenchymal transition in high glucose-induced HK-2 cells by miR-21-5p/Smad7-mediated pathway. |
Abbreviations : DMDD, DKD, HK-2 cells, HG, CCK-8, CKD, ESRD, RAAS, EMT, ZO-1, FSP-1, TGFβ, TGFβR Ⅱ, MiR-21, UTR, ECM, FBS, SGLT2, GLP-1
Keywords : DMDD, Diabetic kidney disease, Epithelial-mesenchymal transition, MiR-21–5p, Smad7
Plan
Vol 172
Article 116280- mars 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?